Background. The Jewish population of Israel is divided into two ethnic
groups: Ashkenazic Jews (AJ) who immigrated from Europe and are fair-
skinned, and Sephardic Jews (SJ) who immigrated from the Orient and Af
rica and who are dark-skinned. The biologic behavior of malignant mela
noma (MM) in these two groups has not been investigated. Methods. Thre
e hundred forty-eight of 380 patients with MM, who could be accurately
grouped ethnically, constitute this study group. The gender, site and
depth of primary tumor, metastatic involvement and survival analysis,
including univariate analysis for level of invasion, were examined. R
esults. Of 348 patients with MM, 285 were AJ and 63 were SJ. The femal
e:male ratio was 2:1 and 0.9:1, for AJ and SJ, respectively (P < 0.05)
. Lesion site distribution was similar. The lesions were more invasive
in SJ, 53% Clark level 4-5 versus 41% in AJ (P < 0.05). The 5-year su
rvival was worse in SJ relative to AJ-50% versus 71% for female patien
ts and 30% versus 62% for male patients-but did not reach statistical
significance (NS). The actuarial 10-year survival showed poorer surviv
al for female SJ: 27% versus 67% in female AJ (P < 0.05) and male SJ;
32% versus 65% in male AJ (P < 0.01). For all Stage I MM, the actuaria
l 10-year survival was in male patients 32% versus 79% (P < 0.05), and
in female patients, 27% versus 72% (P < 0.05) in SJ and AJ, respectiv
ely. For the more invasive lesions (Clark levels 4 and 5), the actuari
al 10-year survival was for male patients 19% versus 75% (P < 0.05) an
d for female patients, 65% versus 67% (NS) in SJ and AJ, respectively.
Conclusions. The dark-skinned SJ tend to have MM less than the fair-s
kinned AJ, but once MM occurs in SJ, it appears to have a more virulen
t nature.